logo

TTRX

Turn·NASDAQ
--
--(--)
--
--(--)

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About TTRX

Turn Therapeutics Inc.

Dedicated to improving healthcare systems in low-and middle-income countries

Life Science Tools and Services
01/06/2015
10/08/2025
NASDAQ Stock Exchange
2
12-31
Common stock
250 N. Westlake Blvd. Westlake Village CA 91362
--
Turn Therapeutics Inc., originally formed on January 6, 2015, is a Delaware limited liability company. The company is a pharmaceutical and medical device development company with core technologies based on proprietary platforms designed to enhance drug performance. Its patented blending process — commercially known as PermaFusion — enables the stable suspension of polar water-soluble active pharmaceutical ingredients (" APIs ") in oily carriers without the use of emulsifiers. Its main development projects focus on skin diseases, including moderate to severe eczema and onychomycosis.

Company Financials

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime

No Data